Future Trends in Refractive Surgery

Future Trends in Refractive Surgery

Future Trends in Refractive Surgery

On this page

Next-Gen LVC - Laser Sharp Futures

  • Femtosecond Laser Advancements:
    • Higher frequency (> 1 MHz), lower energy systems: Smoother cuts, reduced inflammation, faster recovery.
    • Robotic assistance: Enhanced precision, improved docking, and surgical consistency.
  • Novel Ablation Profiles & Techniques:
    • SILK (Smooth Incision Lenticule Keratomileusis): Advanced lenticule extraction.
    • CAIRS (Corneal Allogenic Intrastromal Ring Segments): For keratoconus management.
    • Sophisticated topography-guided ablations & presbyopia-correcting profiles (e.g., PresbyMAX).
  • AI Integration in LVC:
    • Pre-op: AI-driven personalized nomograms, advanced risk stratification.
    • Intra-op: AI for real-time eye tracking, cyclotorsion compensation.
    • Post-op: AI for predictive modeling of outcomes. SMILE procedure steps

⭐ SILK (Smooth Incision Lenticule Keratomileusis) by J&J Vision aims for improved outcomes by creating biconvex lenticules and smoother stromal beds, potentially offering quicker visual recovery.

Advanced Lens Solutions - Intelligent Lens Innovations

  • Extended Depth of Focus (EDOF) IOLs:
    • Provide a continuous range of vision, reducing spectacle dependence.
    • Work by creating a single elongated focal point, unlike multifocal distinct points.
    • May have fewer halos/glare issues compared to older multifocal IOLs.
  • Trifocal IOLs:
    • Offer clear vision at near, intermediate, and distant focal points.
    • Aim to provide greater spectacle independence.
  • Accommodating IOLs (AIOLs):
    • Designed to mimic the eye's natural accommodation by changing focus.
    • Mechanisms: axial movement, shape change, or refractive index shift.
    • Current generation offers limited but improving accommodative amplitude.
  • Phakic IOLs Evolution:
    • Improved materials (e.g., collamer) and designs (e.g., central port for aqueous flow - reduces cataract/glaucoma risk).
    • Wider range of dioptric correction.
  • Minimally Invasive Techniques:
    • Preloaded IOL injectors for smaller incisions.
    • Femtosecond laser-assisted lens surgery for precision.

Trifocal GP IOL light path, through-focusing, and MTF

Light Adjustable Lens (LAL): Allows non-invasive, post-operative refinement of sphere, cylinder, and EDOF profile using UV light, offering precise visual outcomes. This is a significant advancement in customizable vision correction after cataract surgery or refractive lens exchange (RLE).

Corneal Biomechanics & Regeneration - Cornea's Comeback Crew

  • Corneal Biomechanics: Assesses corneal strength (CH, CRF); vital for ectasia risk.
  • Advanced Cross-Linking (CXL): Halts ectasia. Standard (Dresden): 3 $mW/cm^2$, 30min.
    • Epi-on CXL: Transepithelial, ↓pain, faster recovery.
    • Accelerated CXL: ↑UVA (e.g., 9 $mW/cm^2$, 10min), ↓duration.
    • CXL Xtra/Plus: CXL with PRK/ICRS.
  • Expanded CXL Horizons:
    • Thin Corneas (<400 $\mu m$): With hypo-osmolar riboflavin.
    • Infectious Keratitis (IK): Pack-CXL as adjunct therapy.
  • Corneal Regeneration:
    • Endothelial Cell Therapy: Cultured cells for endothelial dysfunction.
    • Bioengineered Corneas: Stromal analogues, 3D bioprinting.
    • Lenticule Re-implantation: SMILE lenticules for hyperopia/aphakia. 📌 ReLACS Diagram of CXL techniques

⭐ Corneal Allogenic Intrastromal Ring Segments (CAIRS) using donor cornea are emerging for keratoconus, offering better biocompatibility than synthetic ICRS.

Pharmacological & Novel Approaches - Drug & Gene Dreams

  • Presbyopia Eye Drops:
    • Miotics (e.g., Pilocarpine HCl 1.25% - Vuity): ↑ depth of focus via miosis.
    • Lens softening agents (experimental): Aim to restore accommodation.
  • Pharmacological Myopia Control:
    • Low-dose Atropine (0.01% - 0.05%): Most effective, slows progression. Mechanism: non-accommodative, acts on scleral/retinal receptors.
    • Pirenzepine (M1 antagonist), 7-Methylxanthine (adenosine antagonist) - less common.
  • Gene Therapy (Investigational):
    • Targets: Scleral remodeling genes (e.g., collagen, MMPs), growth factors (e.g., TGF-β).
    • Goal: Modulate eye growth, scleral biomechanics to prevent/correct myopia.
    • Vectors: Adeno-Associated Virus (AAV) commonly explored.

⭐ Low-dose atropine (0.01%) is a widely recognized pharmacological intervention for effectively slowing myopia progression in children, with minimal side effects compared to higher concentrations.

High‑Yield Points - ⚡ Biggest Takeaways

  • Lenticule extraction advancements like SMILE Pro & CLEAR promise faster, wider applications.
  • Highly personalized ablations using topography-guided & wavefront-optimized techniques are increasing.
  • Novel presbyopia solutions include advanced corneal inlays, presbyLASIK, and scleral procedures.
  • Light Adjustable IOLs (LAL) offer precise, non-invasive post-operative refractive adjustment.
  • Pharmacological myopia control (e.g., low-dose atropine) and CXL alternatives are key research areas.
  • Artificial Intelligence (AI) is enhancing patient selection, surgical planning, and outcome prediction.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Future Trends in Refractive Surgery

Test your understanding with these related questions

Which of the following is the optimal position for inserting an IOL during a cataract surgery?

1 of 5

Flashcards: Future Trends in Refractive Surgery

1/9

Hyperopic photorefractive keratotomy is used for treatment of _____

TAP TO REVEAL ANSWER

Hyperopic photorefractive keratotomy is used for treatment of _____

hypermetropia (hypermetropia/myopia)

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free